Home › Research › Lewy body dementia
The association between plasma and MRI biomarkers in dementia with lewy bodies
Carmen Peña‐Bautista, Katharina Bolsewig, Maria Camila González, Nicholas James Ashton, Dag Aarsland, Henrik Zetterberg, Eric Westman, Olivier Bousiges et al.. Alzheimer s Research & Therapy, 2025-08-22
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
In DLB, plasma concentrations of GFAP and NfL were associated with MTA, GCA-F, and Fazekas scale; and the Aβ42/40 ratio was associated with PA and Fazekas. Most of these associations were not statistically significant in AD. Individually, plasma and MRI biomarkers had a limited ability to discriminate DLB from AD. Plasma biomarkers helped increase the low specificity of core clinical features from 68% up to 79%, keeping the high sensitivity of 90%. Plasma biomarkers of AD co-pathology, glial processes and unspecific neurodegeneration are associated with MRI biomarkers of atrophy and cerebrovascular disease in DLB patients. Plasma biomarkers increase the ability of core clinical features to discriminate between DLB and AD.
What this study adds
Evidence grade: Low
The record lists 92 participants. This is about improving diagnosis, not about treating, curing or preventing the disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Peña‐Bautista, C., Bolsewig, K., González, M. C., Ashton, N. J., Aarsland, D., Zetterberg, H., et al. (2025). The association between plasma and MRI biomarkers in dementia with lewy bodies. Alzheimer s Research & Therapy. https://doi.org/10.1186/s13195-025-01848-x
Vancouver
Peña‐Bautista C, Bolsewig K, González MC, Ashton NJ, Aarsland D, Zetterberg H, et al. The association between plasma and MRI biomarkers in dementia with lewy bodies. Alzheimer s Research & Therapy. 2025. doi:10.1186/s13195-025-01848-x. PMID: 40847319.
BibTeX
@article{penabautista2025-40847319,
author = {Peña‐Bautista, Carmen and Bolsewig, Katharina and González, Maria Camila and Ashton, Nicholas James and Aarsland, Dag and Zetterberg, Henrik and Westman, Eric and Bousiges, Olivier and others},
title = {{The association between plasma and MRI biomarkers in dementia with lewy bodies}},
journal = {Alzheimer s Research \& Therapy},
year = {2025},
doi = {10.1186/s13195-025-01848-x},
pmid = {40847319},
url = {https://doi.org/10.1186/s13195-025-01848-x}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- In DLB, plasma concentrations of GFAP and NfL were associated with MTA, GCA-F, and Fazekas scale; and the Aβ42/40 ratio was associated with PA and Fazekas.
- Most of these associations were not statistically significant in AD.
- Individually, plasma and MRI biomarkers had a limited ability to discriminate DLB from AD.
- Plasma biomarkers helped increase the low specificity of core clinical features from 68% up to 79%, keeping the high sensitivity of 90%.
- Plasma biomarkers of AD co-pathology, glial processes and unspecific neurodegeneration are associated with MRI biomarkers of atrophy and cerebrovascular disease in DLB patients.
Why it matters
In dementia with Lewy bodies, plasma GFAP and NfL were associated with MRI measures of atrophy and cerebrovascular disease, and adding plasma biomarkers raised the specificity of core clinical features for distinguishing DLB from Alzheimer's disease from 68% to 79% while keeping sensitivity at 90%. This is about improving diagnosis, not about treating, curing or preventing the disease.
Study details
- Participants92
- Evidence strengthLow
How this study scored 44/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s Research & Therapy) |
| Journal's citation record | 1 / 4 | Alzheimer s Research & Therapy: journal h-index 146 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 1 / 4 | 92 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 4 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 2.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 4 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Daniel Ferreira: h-index 41 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | Centre National de la Recherche Scientifique: institution h-index 2,511 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 19 institution(s) in 7 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40847319) |
| Free to read | 2 / 2 | Free to read |
| Total | 44 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1186/s13195-025-01848-x
- PubMed: 40847319
- Original source →
- Free full text: Alzheimer s Research & Therapy →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 17.
Related studies in Lewy body dementia from nearby years
Also tagged “lewy”
1,017 studies in the library carry the topic tag “lewy”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,017 tagged studies.